The current debate over the provision of Consumer Medicine Information leaflets (CMIs) misses the fundamental point of patient health literacy, says Anthony Tassone It is perhaps a measure of the …

What are the symptoms of burnout, and how can you protect yourself against it during the busy holiday season? Kay Dunkley from the Pharmacists’ Support Service explains Research looking at …

We present the top 10 weirdest science stories of 2018, courtesy of the Australian Science Media Centre Scientists gave octopuses ecstasy and they started hugging In a classic piece of …

by David Clayton, Nottingham Trent University With a global diet industry worth US$168.95 billion, it’s clear the world is obsessed with weight loss. But what’s the best diet for losing …

by Stephen Bright, Edith Cowan University and Nicole Lee, Curtin University Media reports last week linked the use of “nangs” to the death of a teenager at schoolies week on …

How assembly line theory can help maximise efficiency and effectiveness in community pharmacy, by Glenn Guilfoyle Readers of the trade press over recent months will have had opportunity to digest the …

Capital Chemist is celebrating 40 years of providing early-career community pharmacists with rewarding work environments and empowered professional roles Are you a future community pharmacy leader? Are you passionate, inspired, …

Apart from the relatively new retailing sales event, called Black Friday, the 23rd November 2018 has further significance, writes Phillip Chapman It’s not for retail sales, but for retail sales …

by Shalini Arunogiri, Monash University; Dan Lubman, Monash University, and Rose Crossin, Monash University Pregabalin (sold under the brand name Lyrica) is prescribed as an anti-epileptic and a painkiller for …

Over recent years, a number of products have emerged that claim to prevent or cure hangovers if consumed while drinking or the morning after… but do they really work? By …

What are the lessons from the recent pharmacy valuation season? John Thornett explains Since 30 June 2018 valuation activity has certainly been very high. We have seen activity pick up …

Donald Trump’s plan to bring down the skyrocketing cost of prescription medication in the US has potential to see prices increase in other parts of the world, writes Matthew Bellgrove …